Walleye Trading
LJPC

Walleye Trading’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Walleye Trading’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,540
Closed -$95K – 4903
2020
Q1 		$95K Sell
22,540
-8,975
-28% -$56.7K ﹤0.01% 3149
2019
Q4 		$124K Buy
+31,515
New +$186K ﹤0.01% 3455
2016
Q2 		– Sell
-100
Closed -$2K – 6214
2016
Q1 		$2K Buy
+100
New +$1.78K ﹤0.01% 5164

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Walleye Trading's LJPC Position: Q2 2020 in Review

Walleye Trading sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 22,540 shares — an estimated $95K sold.

Walleye Trading first reported a position in LJPC in Q1 2016 and held it in 3 quarters. The position peaked at $124K in Q4 2019. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Walleye Trading reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Walleye Trading sold 22,540 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $95K.
  • Walleye Trading first reported a position in La Jolla Pharmaceutical Company in Q1 2016 and held it in 3 quarters.
  • Walleye Trading's La Jolla Pharmaceutical Company position peaked at $124K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.